Lisa Kuhen, NP
Adult Health · Willoughby Hills, OHNPI 1073607123
Payments from drug & device makers
Across 111 payments — averaging $14.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$896
- AstraZeneca$183
- Teva Pharmaceuticals USA, Inc.$83
- Vapotherm Inc$79
- Regeneron Healthcare Solutions, Inc.$55
- Sanofi$52
- plus $271 from 9 others
What the payments were for
- Food & beverage$1,619100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 76 | $896 |
| AstraZeneca | 11 | $183 |
| Teva Pharmaceuticals USA, Inc. | 4 | $83 |
| Vapotherm Inc | 1 | $79 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| Sanofi | 3 | $52 |
| Amgen | 2 | $48 |
| Mylan Specialty L.p. | 2 | $43 |
| Merck | 2 | $40 |
| Philips North America LLC | 2 | $36 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| Sunovion Pharmaceuticals Inc. | 2 | $22 |
| Boehringer Ingelheim | 1 | $21 |
| La Jolla Pharmaceutical Company | 1 | $17 |
| Pfizer | 1 | $15 |
How this compares
$1,619 in reported general payments places this provider in the 75th percentile of 1,184 adult health providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 543 | $428,928 |
| Breo ElliptaFluticasone/Vilanterol | 165 | $92,850 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 121 | $83,857 |
| Spiriva RespimatTiotropium Bromide | 83 | $75,254 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 65 | $39,732 |
| Spiriva HandihalerTiotropium Bromide | 57 | $35,047 |
| SymbicortBudesonide/Formoterol Fumarate | 58 | $23,546 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $20,918 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 78 | $15,530 |
| Arnuity ElliptaFluticasone Furoate | 33 | $14,933 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 410 | $11,969 |
| DuleraMometasone/Formoterol | 19 | $11,339 |
| Incruse ElliptaUmeclidinium Bromide | 27 | $11,249 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 65 | $8,887 |
| EliquisApixaban | 14 | $8,402 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta, Incruse Ellipta | $896 | $631,818889 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $21 | $114,986148 claims |
| AstraZenecaSymbicort, Breztri Aerosphere | $183 | $44,46581 claims |
| MerckDulera | $40 | $11,33919 claims |
| PfizerEliquis | $15 | $8,40214 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $83 | $4,16712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,184 adult health providers in Ohio.
Other adult health in Willoughby Hills
- Bonnie MohlerCanton$338K
- Andrew GuinigundoCincinnati$215K
- Gabriella McCartyWestlake$177K
- Karen SteffeyLyndhurst$145K
- Marie ChambersCenterville$134K
- Susan FlickCleveland$131K
- Margaret TiktinCleveland$105K
- Teresa ShafferBoardman$102K
- Jesse McClainYoungstown$79K
- Lucretia LongColumbus$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.